US-based Mural Health has announced a strategic partnership with China-based Clinflash, both companies specializing in providing patient-focused services and solutions during the clinical trial process. This collaboration will see Mural Health leveraging Clinflash’s specialist IT capabilities to expand the capacity and global market reach of patient payments for clinical trials.
Core Technology Integration and Global Expansion
Through this partnership, Mural Health and Clinflash are pairing their core technologies to enhance the clinical trial experience. Mural Health has developed Mural Link, a next-generation patient payments platform designed to recruit patients for trials. Clinflash, on the other hand, has developed ePAY, a clinical trial electronic payment solution that utilizes digital technology to improve payment efficiency and safeguard trial participants, including patients, sponsors, and hospitals.
Clinflash’s Extensive Network and Mural Health’s Market Access
Clinflash boasts ‘dozens’ of relationships with Chinese hospitals, serving as a third-party payment platform for trial participants. This partnership specifically expands Mural Health’s access to the Chinese clinical trial market but also paves the way for potential expansion into other countries, demonstrating a shared commitment to improving global clinical trial processes.-Fineline Info & Tech
